Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

The recent reduction of live attenuated influenza vaccine (LAIV) effectiveness in multivalent formulations was particularly associated with the A(H1N1)pdm09 component. In the 2017 the WHO vaccine composition committee changed its recommendations for the A(H1N1)pdm09 component to include an A/Michiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Shcherbik, Svetlana, Pearce, Nicholas, Carney, Paul, Bazhenova, Ekaterina, Larionova, Natalie, Kiseleva, Irina, Rudenko, Larisa, Kumar, Amrita, Goldsmith, Cynthia S., Dugan, Vivien, Stevens, James, Wentworth, David E., Bousse, Tatiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://www.ncbi.nlm.nih.gov/pubmed/31384746
http://dx.doi.org/10.1016/j.jvacx.2019.100031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668239/
https://www.ncbi.nlm.nih.gov/pubmed/31384746
http://dx.doi.org/10.1016/j.jvacx.2019.100031

Ejemplares similares